express
on 30 Aug 2023
Last Applicant/ Owned by
STE 209
REXBERG
ID
83440
Serial Number
88044315 filed on 19th Jul 2018
Registration Number
N/A
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing temporary use of on-line non-downloadable software for use by healthcare providers in learning about, diagnosing and treating clinical disorders influenced by molecular factors; Providing temporary use of on-line non-downloadable software for the collection in consulting on, and soliciting consultation regarding, patient treatment options or clinical trials; Providing temporary use of on Read More
Providing temporary use of on-line non-downloadable software for use by healthcare providers in learning about, diagnosing and treating clinical disorders influenced by molecular factors; Providing temporary use of on-line non-downloadable software for the collection in consulting on, and soliciting consultation regarding, patient treatment options or clinical trials; Providing temporary use of on-line non-downloadable software for use in identifying and recruiting patients for clinical trials; providing a website for patients diagnosed with genetic disorders or cancer to post information in the nature of de-identified genetic profiles online to be used for the purpose of recruitment for clinical trials; all of the foregoing related to clinical trials
No 88044315
No Service Mark
No 10150-0005
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Aug 2023 | ABANDONMENT - EXPRESS MAILED |
30th Aug 2023 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
09th Nov 2022 | ACTION CONTINUING A FINAL - COMPLETED |
09th Nov 2022 | CONTINUATION OF FINAL REFUSAL E-MAILED |
09th Nov 2022 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
08th Nov 2022 | FINAL REFUSAL WRITTEN |
08th Nov 2022 | FINAL REFUSAL E-MAILED |
08th Nov 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
27th Oct 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
26th Oct 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |